Dr. Marcelle M. Morcos, MD

Dr. Morcos practices at Nassau University Medical Center in East Meadow, New York, part of NuHealth.

Dr. Morcos' NPI, 1710954169, was assigned on March 3, 2006. Dr. Morcos graduated from Cairo University School of Medicine in 1969. Dr. Morcos holds New York license 141730.

Dr. Morcos' primary practice is Nassau University Medical Center, at 2201 Hempstead Turnpike, East Meadow, NY 11554 in Nassau County. The practice phone is (516) 572-0123.

Dr. Morcos' primary practice is Nassau University Medical Center in East Meadow, New York, part of NuHealth. The medical group on file is Nassau University Medical Center (NUMC), Department of Psychiatry and Behavioral Sciences. Dmand AI also links Dr. Morcos to 1 more hospital, named with a free account. Dr. Morcos' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Morcos practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Morcos' primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Morcos is licensed in New York.

CMS data shows 148 Medicare services from Dr. Morcos across 5 procedure codes in 2024, for 101 Medicare patients. Medicare paid $9,294 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 101 Medicare patients who saw Dr. Morcos in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 71% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Morcos' median patient age at 61, with 63% women.

In 2024, Dr. Morcos wrote 35 Medicare Part D claims for 18 patients. 74% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $231 in total drug cost. In 2022, CMS named 34 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Morcos for performance year 2024, reported as part of a group. Dr. Morcos accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Morcos, published from 2017 to 2022. 2022 was the busiest year, with 4. Dr. Morcos has published most often in Cornea. Dr. Morcos' most frequent co-authors are Henry D. Perry, MD, Peter Wawrzusin, MD and Tyler Daniel Wickas, MD.

CMS Open Payments shows 38 general payments to Dr. Morcos from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Valeant Pharmaceuticals International paid the most, $702.

Dr. Morcos graduated from Cairo University School of Medicine in 1969.